294 related articles for article (PubMed ID: 34919633)
1. Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.
Xhima K; Markham-Coultes K; Hahn Kofoed R; Saragovi HU; Hynynen K; Aubert I
Brain; 2022 Aug; 145(8):2806-2822. PubMed ID: 34919633
[TBL] [Abstract][Full Text] [Related]
2. Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer's disease.
Xhima K; Markham-Coultes K; Nedev H; Heinen S; Saragovi HU; Hynynen K; Aubert I
Sci Adv; 2020 Jan; 6(4):eaax6646. PubMed ID: 32010781
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration.
Capsoni S; Tiveron C; Vignone D; Amato G; Cattaneo A
Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12299-304. PubMed ID: 20566851
[TBL] [Abstract][Full Text] [Related]
4. The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology.
Canu N; Amadoro G; Triaca V; Latina V; Sposato V; Corsetti V; Severini C; Ciotti MT; Calissano P
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632177
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor P75.
Culmsee C; Gerling N; Lehmann M; Nikolova-Karakashian M; Prehn JH; Mattson MP; Krieglstein J
Neuroscience; 2002; 115(4):1089-108. PubMed ID: 12453482
[TBL] [Abstract][Full Text] [Related]
6. A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression.
Simmons DA; Knowles JK; Belichenko NP; Banerjee G; Finkle C; Massa SM; Longo FM
PLoS One; 2014; 9(8):e102136. PubMed ID: 25153701
[TBL] [Abstract][Full Text] [Related]
7. Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells.
Cattaneo A; Capsoni S
Pharmacol Res; 2019 Jan; 139():17-25. PubMed ID: 30391352
[TBL] [Abstract][Full Text] [Related]
8. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
9. NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits.
Triaca V; Ruberti F; Canu N
Adv Exp Med Biol; 2021; 1331():145-165. PubMed ID: 34453297
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
Counts SE; Che S; Ginsberg SD; Mufson EJ
J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
[TBL] [Abstract][Full Text] [Related]
11. Effects of Reactive Oxygen and Nitrogen Species on TrkA Expression and Signalling: Implications for proNGF in Aging and Alzheimer's Disease.
Kropf E; Fahnestock M
Cells; 2021 Aug; 10(8):. PubMed ID: 34440751
[TBL] [Abstract][Full Text] [Related]
12. Changes in Plasma β-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.
Crispoltoni L; Stabile AM; Pistilli A; Venturelli M; Cerulli G; Fonte C; Smania N; Schena F; Rende M
J Alzheimers Dis; 2017; 55(3):1005-1017. PubMed ID: 27802234
[TBL] [Abstract][Full Text] [Related]
13. Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage.
Gonzalez S; McHugh TLM; Yang T; Syriani W; Massa SM; Longo FM; Simmons DA
Neurobiol Dis; 2022 Jan; 162():105563. PubMed ID: 34838668
[TBL] [Abstract][Full Text] [Related]
14. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease.
Jordão JF; Ayala-Grosso CA; Markham K; Huang Y; Chopra R; McLaurin J; Hynynen K; Aubert I
PLoS One; 2010 May; 5(5):e10549. PubMed ID: 20485502
[TBL] [Abstract][Full Text] [Related]
15. Neurotrophin Responsiveness of Sympathetic Neurons Is Regulated by Rapid Mobilization of the p75 Receptor to the Cell Surface through TrkA Activation of Arf6.
Hickman FE; Stanley EM; Carter BD
J Neurosci; 2018 Jun; 38(24):5606-5619. PubMed ID: 29789375
[TBL] [Abstract][Full Text] [Related]
16. Identification of amino acid residues of nerve growth factor important for neurite outgrowth in human dorsal root ganglion neurons.
Dahlström M; Nordvall G; Sundström E; Åkesson E; Tegerstedt G; Eriksdotter M; Forsell P
Eur J Neurosci; 2019 Nov; 50(9):3487-3501. PubMed ID: 31301255
[TBL] [Abstract][Full Text] [Related]
17. NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease.
Triaca V; Sposato V; Bolasco G; Ciotti MT; Pelicci P; Bruni AC; Cupidi C; Maletta R; Feligioni M; Nisticò R; Canu N; Calissano P
Aging Cell; 2016 Aug; 15(4):661-72. PubMed ID: 27076121
[TBL] [Abstract][Full Text] [Related]
18. Spatio-temporal expression profile of NGF and the two-receptor system, TrkA and p75NTR, in experimental autoimmune encephalomyelitis.
Delivanoglou N; Boziki M; Theotokis P; Kesidou E; Touloumi O; Dafi N; Nousiopoulou E; Lagoudaki R; Grigoriadis N; Charalampopoulos I; Simeonidou C
J Neuroinflammation; 2020 Jan; 17(1):41. PubMed ID: 31996225
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease.
Lad SP; Neet KE; Mufson EJ
Curr Drug Targets CNS Neurol Disord; 2003 Oct; 2(5):315-34. PubMed ID: 14529363
[TBL] [Abstract][Full Text] [Related]
20. Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.
Parikh V; Howe WM; Welchko RM; Naughton SX; D'Amore DE; Han DH; Deo M; Turner DL; Sarter M
Eur J Neurosci; 2013 Jan; 37(2):278-93. PubMed ID: 23228124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
